599792 Disclosed is an immunomodulatory polypeptide derived from IL-2, which comprises point mutations in respect to the sequence of human IL-2, wherein the polypeptide is selected from the group consisting of (i) said polypeptide comprising mutations Q22V, Q126A, and S130G I129D; (ii) said polypeptide comprising mutations L18N, Q126Y and S130R; (iii) said polypeptide comprising mutations Q13Y, Q126Y, I129D and S130R; and (iv) said polypeptide comprising mutations L18N, Q22V, T123A, and S130R I129D.